The vitamin K administered by hospitals to newborns is the synthetic phytonadione.
Toxic ingredients accompanying the Vitamin K
The vitamin K injections administered by hospitals and manufactured by Merck and Roche and Abbott contain benzyl alcohol as a preservative. The 1989 PDR states that, “there is no evidence to suggest that the small amount of benzyl alcohol contained in AquaMEPHYTON (Merck’s vitamin K injection product), when used as recommended, is associated with toxicity.” Interestingly, in November 1988, the French medical journal, Dev Pharmacol Ther, published a paper regarding benzyl alcohol metabolism and elimination in babies. The report stated that “…we cannot directly answer the issue of safety of ‘low doses’ of benzyl alcohol as found in some medications administered to neonates. This study confirms the immaturity of the benzoic acid detoxification process in premature newborns.”
Roche’s vitamin K product KONAKION contains ingredients such as phenol (carbolic acid-a poisonous substance distilled from coal tar), propylene glycol (derived from petroleum and used as an antifreeze and in hydraulic brake fluid) and acetic acid (an astringent antimicrobial agent that may drastically reduce the amount of natural vitamin K that would have otherwise been produced in the digestive tract). As reported in the PDR and as published in the IM vitamin K packet inserts for Merck, Roche and Abbott, “Studies of carcinogenicity, mutagenesis or impairment of fertility have not been conducted with Vitamin K1 Injection (Phytonadione Injection, USP).”
The Vitamin K injection can be in a base of polyethoxylated castor oil.
Vitamin K injections also contain hydrochloric acid and lecithin.